Metabolomics definition

Metabolomics means the comprehensive measurement of numerous metabolites discovered in and among complex biological samples combined with data evaluation methods, such as pattern recognition techniques, with the goal of identifying one or more metabolites that may accurately distinguish individual study cohorts. Metabolomics includes, but is not limited to the area of biofluids/biological sample analysis employing instrumental analytical techniques such as, but not limited to, nuclear magnetic resonance (“NMR”), mass spectrometry (“MS”), chromatography, capillary electrophoresis (“CE”), inductively coupled plasma mass spectrometry (“ICP-MS”) and atomic emission spectrometry (“AES”). Metabolomics does not include the direct measurement and identification of specific individual metabolites or groups of specific individual metabolites as may be performed, for example, in the course of toxicological studies.

Examples of Metabolomics in a sentence

  • The Division is comprised of six Centers of Excellence (Chemistry, Functional Genomics, Hepatotoxicology, Metabolomics, Proteomics and Toxicoinformatics) and an Immediate Office.

  • The Harmony of Molecular Services and Molecular Diagnostics Molecular Services Proteomics Metabolomics Biotherapeutics Imaging Molecular Diagnostics/Prognostics Melanoma (Proteomic/Metabolomic) Esophageal (Proteomic/Metabolomic) Ovarian (Proteomic/Biotherapeutic) Wound Healing (Proteomic/Biotherapeutic) Immunotherapy (Biotherapeutic) Commercial Molecular Services Division enables Molecular Diagnostics Division through in house expertise, industry partnerships, and market and commercial need.

  • Metabolomics is important because quantifying and understanding the full picture of circulating biochemicals in the body can help researchers get a clearer picture of that individual’s health status and provide markers and pathways associated with disease and drug action.

  • The purpose of this Agreement is to establish the conditions under which the parties hereto will determine the specifics of the future business relationship and cooperation between BG and TNO in the area of Metabolomics.

  • BG and TNO are interested in working together in the area of Metabolomics.

Related to Metabolomics

  • Biomarker means a parameter or characteristic in a patient or Patient Sample, the measurement of which is useful (a) for purposes of selecting appropriate therapies or patient populations or monitoring disease susceptibility, severity or state, or monitoring therapies for such patient and/or (b) for predicting the outcome of a particular treatment of such patient.

  • scientific research means any activity in the field of natural or applied science for the extension of knowledge;

  • Novartis shall have the meaning set forth in the Preamble.

  • Merck has the meaning set forth in the preamble.

  • coronavirus means severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2);

  • BMS means the Company, all related companies, affiliates, subsidiaries, parents, successors, assigns and all organizations acquired by the foregoing.

  • Assay means a laboratory analysis of Crude Petroleum to include the following: A.P.I. Gravity, Reid vapor pressure, composition, pour point, water and sediment content, sulfur content, viscosity, distillation, hydrogen sulfide, flash/boiling point and other characteristics as may be required by Carrier.

  • Cannabinoid means any of the chemical compounds that are the active constituents of marijuana.

  • Commercialization or “Commercialize” means any and all activities undertaken at any time for a particular Licensed Product and that relate to the manufacturing, marketing, promoting, distributing, importing or exporting for sale, offering for sale, and selling of the Licensed Product, and interacting with Regulatory Authorities regarding the foregoing.

  • Cannabis means all parts of the plant Cannabis sativa Linnaeus, Cannabis indica, or Cannabis ruderalis, whether growing or not; the seeds thereof; the resin, whether crude or purified, extracted from any part of the plant; and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seeds, or resin. “Cannabis” also means the separated resin, whether crude or purified, obtained from cannabis. “Cannabis” does not include the mature stalks of the plant, fiber produced from the stalks, oil or cake made from the seeds of the plant, any other compound, manufacture, salt, derivative, mixture, or preparation of the mature stalks (except the resin extracted therefrom), fiber, oil, or cake, or the sterilized seed of the plant which is incapable of germination. For the purpose of this division, “cannabis” does not mean “industrial hemp” as defined by Section 11018.5 of the Health and Safety Code.

  • DS Electric generation service that is provided at retail pursuant to the Applicable Legal Authorities under the Company’s retail electric tariffs and under any other agreements or arrangements between the Company and Customers, to any Customer that is not being served by an EGS. Default Allocation Assessment – shall have the meaning ascribed to it under the PJM Agreements. Delivery Period – The delivery period specified in an Appendix C Transaction Confirmation. Delivery Point – Means the applicable zone of the Company as designated by PJM. DS Customer(s) – Retail customers who are provided Default Service pursuant to the terms of this Agreement, the Applicable Legal Authorities and the Company’s retail tariffs.

  • mg means milligram.

  • Biological Samples means any physical samples obtained from Study Participants in accordance with the Protocol for the purposes of the Study.

  • Clinical means having a significant relationship, whether real or potential, direct or indirect, to the actual rendering or outcome of dental care, the practice of dentistry, or the quality of dental care being rendered to a patient;

  • Vaccine means a specially prepared antigen which, upon administration to a person, will result in immunity and, specifically for the purposes of this rule, shall mean influenza and pneumococcal vaccines.

  • Biological agent shall mean any pathogenic (disease producing) micro-organism(s) and/or biologically produced toxin(s) (including genetically modified organisms and chemically synthesized toxins) which cause illness and/or death in humans, animals or plants.